Showing results (1781-1790 of 2,037) with videos related to

Sort By:
Pageof 204
Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists|June 30, 2025
Safety and Efficacy of Endovascular Treatment Modalities for Below-the-Knee Arterial Disease: A Systematic Review and Network Meta-analysisDaniela Tirziu, Amr Saleh, Haocheng Huang, et al.
European Urology Oncology|November 4, 2024
Olaparib plus Abiraterone for Metastatic Castration-resistant Prostate Cancer: Pharmacokinetics Data from the PROpel TrialAndrew J Armstrong, Noel Clarke, Mototsugu Oya, et al.
BMJ Open Gastroenterology|March 22, 2024
Study protocol for a Randomised controlled trial of EArly transjugular intrahepatiC porTosystemic stent-shunt in Acute Variceal Bleeding (REACT-AVB trial)Dhiraj Tripathi, David Patch, Homoyon Mehrzad, et al.
Movement Disorders Clinical Practice|April 1, 2026
MDS Global Survey on Work Environment, Career Advancement, and Work-Life Balance in Movement Disorders Professionals: Gender and Regional PatternsVeronica Bruno, Marina Picillo, Elena Moro, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|February 9, 2018
CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver diseaseRichard Parker, Christopher J Weston, Zhenhua Miao, et al.
The British Journal of Dermatology|May 7, 2019
Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomasR Ellis, D Tang, B Nasr, et al.
European Urology|May 13, 2023
The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer: A Post Hoc Analysis of ARCHESAndrew J Armstrong, Taro Iguchi, Arun A Azad, et al.
European Urology Oncology|February 18, 2020
Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM TrialRhonda L Bitting, Patrick Healy, Daniel J George, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
NUAK2 is a therapeutically tractable regulator of RNA splicing and tumor progression in neuroendocrine prostate cancerUmar Mehraj, Uran Maimekov, Shaista Manzoor, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 18, 2024
Quality-of-Life Analysis of a Phase II Randomised Controlled Trial Comparing Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy in Locally Advanced Rectal CancerR L Geary, C Gillham, G McVey, et al.
Pageof 204